Search results for: 'biologics contract development'

Radical changes in science and technology are helping the human body evolve. Biological augmentations and body enhancements are transforming the human body and bringing about a kind of transhumanism by eliminating diseases, extending life spans, and enhancing human capabilities. Biological augmentations and body enhancements are classified into th...

Materials science is at the core of every industry, as its innovations will lead to more sustainable manufacturing practices. In this study, we explore sustainable materials, their types, and the innovation observed across several industries. Sustainable materials are classified as follows: 1) Organic Material 2) Natural Biodegradable Polym...

11 Sep 2018  |  Europe  |  Market Research

Growth Opportunities in the Nordic Region Facility Management Market

Service Innovation and Contract Integration to Drive Growth and Industry Transformation

Infographics

×

Key Issues Addressed

The facility management (FM) market in the Nordic region is one of the most advanced in the world, but it's also one of the most mature and revenue growth is becoming hard to find. Companies need to innovate around technology, new business models, emerging value propositions, and creative new service offerings to find ways to deliver profitable an...

In this report, Frost & Sullivan covers construction's global and future aspects, focusing on upcoming trends. The study details opportunities for mobility, industrial, fast-moving consumer goods (FMCG), retail, information and communications technology (ICT), business and financial services, and supply chain and logistics. It offers industry sta...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

This research sets the stage for visionary thinking by identifying the most important Mega Trends in Turkey, potential scenarios of specific trends in 2025, and the implications of these Mega Trends in transforming society, markets, and cultures. It focuses on ten Mega Trends, as identified by Frost & Sullivan. It provides an understanding of impac...

The report provides an overview of the global vaccine market estimating the market size broken down by different segments. Vaccines, though a sub-set of biologics, have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generatio...

14 Jan 2019  |  North America  |  Market Research

Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

Infographics

×

Key Issues Addressed

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...